| Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects (NCT02892370) | Jiangsu HengRui Medicine Co., Ltd. | 2016-08-01 |
| A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin (NCT02951962) | Yuhan Corporation | 2016-08-01 |
| T1DM Immunotherapy Using Polyclonal Tregs + IL-2 (NCT02772679) | Jeffrey Bluestone | 2016-08-01 |
| A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants (NCT02851212) | Janssen Research & Development, LLC | 2016-08-01 |
| Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer (NCT02873416) | Ningbo Cancer Hospital | 2016-08-01 |
| RADVAX™: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy (NCT02880345) | Abramson Cancer Center at Penn Medicine | 2016-08-01 |
| A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects (NCT02958436) | Regeneron Pharmaceuticals | 2016-08-01 |
| Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC (NCT03246659) | Paola Anna Erba | 2016-08-01 |
| A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers (NCT02858973) | Qurient Co., Ltd. | 2016-08-01 |
| Personalized Vaccine for Cancer Immunotherapy (NCT04879888) | Universidad Nacional de Colombia | 2016-08-01 |
| Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 (NCT02894541) | Chong Kun Dang Pharmaceutical | 2016-08-01 |
| Biological Signatures, Probiotic Among Those With mTBI and PTSD (NCT02723344) | VA Office of Research and Development | 2016-08-01 |
| Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects (NCT02966860) | Mallinckrodt | 2016-08-01 |
| Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects (NCT02936154) | Pfizer | 2016-08-01 |
| Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes (NCT03528811) | Shanghai 10th People's Hospital | 2016-08-01 |
| Transcutaneous Vagal Nerve Stimulation: Influence on miRNA, Inflammation, Cerebral Resting State and Gastric Motility (NCT02359188) | Philipps University Marburg | 2016-08-01 |
| A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures (NCT02899611) | Cerebral Therapeutics LLC | 2016-08-01 |
| Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma (NCT02298595) | Julie E. Bauman, MD, MPH | 2016-08-01 |
| 89Zr-AMG211 PET Imaging Study (NCT02760199) | University Medical Center Groningen | 2016-08-01 |
| Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers (NCT03023787) | Shanghai HEP Pharmaceutical Co., Ltd. | 2016-08-01 |
| Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome (NCT02906371) | University of Pennsylvania | 2016-08-01 |
| Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder (NCT02778360) | Mensia Technologies SA | 2016-08-01 |
| Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age (NCT02952339) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-01 |
| Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30 (NCT02873260) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-01 |
| Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers (NCT02931214) | GlycoMimetics Incorporated | 2016-08-01 |
| Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) (NCT02771626) | Calithera Biosciences, Inc | 2016-08-01 |
| Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer (NCT02873520) | Ningbo Cancer Hospital | 2016-08-01 |
| Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers (NCT02916901) | Chong Kun Dang Pharmaceutical | 2016-08-01 |
| A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872 (NCT02888327) | Alios Biopharma Inc. | 2016-07-31 |
| Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE) (NCT02870348) | Grifols Therapeutics LLC | 2016-07-29 |
| Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency (NCT02870309) | Grifols Therapeutics LLC | 2016-07-29 |
| Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine (NCT02868073) | Vaxart | 2016-07-29 |
| A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects (NCT02790125) | Bristol-Myers Squibb | 2016-07-28 |
| Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients (NCT02617407) | University of California, San Francisco | 2016-07-28 |
| Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma (NCT02798536) | National Cancer Institute (NCI) | 2016-07-27 |
| Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg (NCT02753803) | Dong-A ST Co., Ltd. | 2016-07-27 |
| A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects (NCT02844790) | Novo Nordisk A/S | 2016-07-26 |
| A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity (NCT02835235) | Novo Nordisk A/S | 2016-07-26 |
| A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers (NCT03096756) | Galera Therapeutics, Inc. | 2016-07-26 |
| A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis (NCT02867306) | Astellas Pharma Global Development, Inc. | 2016-07-25 |
| Filling Bone Defects/Voids With Autologous BonoFill-II for Maxillofacial Bone Regeneration (NCT02842619) | BonusBio Group Ltd | 2016-07-23 |
| M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02595931) | National Cancer Institute (NCI) | 2016-07-22 |
| Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia (NCT02281500) | Grifols Therapeutics LLC | 2016-07-22 |
| Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas (NCT02740270) | Novartis Pharmaceuticals | 2016-07-22 |
| First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080 (NCT02817100) | Bayer | 2016-07-22 |
| Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer (NCT02503358) | OHSU Knight Cancer Institute | 2016-07-21 |
| Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya (NCT02687373) | Sanaria Inc. | 2016-07-21 |
| Study of SHP620 (Maribavir) in Healthy Adults (NCT02775240) | Shire | 2016-07-21 |
| Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets (NCT02821910) | Boehringer Ingelheim | 2016-07-20 |
| Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma (NCT02743546) | Janssen Research & Development, LLC | 2016-07-20 |
| Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans (NCT03179163) | Penn State University | 2016-07-20 |
| A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult Subjects (NCT03486236) | Vertex Pharmaceuticals Incorporated | 2016-07-20 |
| Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants (NCT02792179) | Hoffmann-La Roche | 2016-07-19 |
| Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis (NCT02718495) | Proteostasis Therapeutics, Inc. | 2016-07-19 |
| Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen® (NCT02762799) | Biocad | 2016-07-18 |
| MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma (NCT02575339) | Kathy Miller | 2016-07-18 |
| AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease. (NCT02826525) | AstraZeneca | 2016-07-18 |
| The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL). (NCT02924753) | Henan Cancer Hospital | 2016-07-18 |
| Oxytocin in Spectrum Autism Disorders (NCT03183674) | University of Sao Paulo General Hospital | 2016-07-15 |
| Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers (NCT03028285) | POLYSAN Scientific & Technological Pharmaceutical Company | 2016-07-15 |
| Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China (NCT03020134) | Ascletis Pharmaceuticals Co., Ltd. | 2016-07-15 |
| Empa/Lina FDC Food Effect Study (Japan) (NCT02815644) | Boehringer Ingelheim | 2016-07-15 |
| Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age (NCT02794870) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-07-15 |
| Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men (NCT02754687) | Premier Research | 2016-07-14 |
| Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer (NCT02672098) | Loma Linda University | 2016-07-14 |
| Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease (NCT02837237) | KBP Biosciences | 2016-07-13 |
| Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC) (NCT02753595) | Eisai Inc. | 2016-07-13 |
| MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023) (NCT02549651) | MedImmune LLC | 2016-07-13 |
| Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT02836418) | aTyr Pharma, Inc. | 2016-07-13 |
| Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function (NCT02808312) | Gilead Sciences | 2016-07-13 |
| Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma (NCT02818023) | Yana Najjar | 2016-07-13 |
| Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM) (NCT02862431) | Janssen Research & Development, LLC | 2016-07-12 |
| Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease (NCT03043742) | Michael Sekela | 2016-07-12 |
| Clinical Trial of GX-I7 in Healthy Volunteers (NCT02860715) | Genexine, Inc. | 2016-07-11 |
| Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1 (NCT02687230) | BioNTech Research & Development, Inc. | 2016-07-11 |
| A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML) (NCT02781467) | Celularity Incorporated | 2016-07-11 |
| A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers (NCT02879877) | UCB Biopharma S.P.R.L. | 2016-07-11 |
| A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) (NCT02817633) | Tesaro, Inc. | 2016-07-08 |
| Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151) (NCT02821000) | Merck Sharp & Dohme LLC | 2016-07-08 |
| Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults (NCT02788045) | Janssen Vaccines & Prevention B.V. | 2016-07-08 |
| Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer (NCT02795819) | Virginia Commonwealth University | 2016-07-08 |
| Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy Participants (NCT02812251) | Janssen-Cilag International NV | 2016-07-07 |
| A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases (NCT02639260) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2016-07-07 |
| Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy (NCT02839694) | National Cancer Institute (NCI) | 2016-07-07 |
| To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days (NCT02733627) | Boehringer Ingelheim | 2016-07-07 |
| Daratumumab in Combination With ATRA (NCT02751255) | Amsterdam UMC, location VUmc | 2016-07-06 |
| Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) (NCT02726997) | M.D. Anderson Cancer Center | 2016-07-06 |
| A Phase I Study of TS-142 in Healthy Participants (Repeated Doses) (NCT04169906) | Taisho Pharmaceutical Co., Ltd. | 2016-07-06 |
| A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma (NCT03189524) | BeiGene | 2016-07-05 |
| A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers (NCT02743455) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-07-05 |
| Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup (NCT02858193) | Dompé Farmaceutici S.p.A | 2016-07-04 |
| A Food Effect Study of TAK-385 Final Formulation (NCT02792062) | Takeda | 2016-07-04 |
| MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD (NCT02876172) | Resilient Pharmaceuticals | 2016-07-03 |
| In Vivo Assessment of Cellular Metabolism in Humans (NCT02748369) | K. Sreekumaran Nair | 2016-07-01 |
| A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405 (NCT02846181) | Sanwa Kagaku Kenkyusho Co., Ltd. | 2016-07-01 |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer (NCT02843815) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years (NCT02787109) | Statens Serum Institut | 2016-07-01 |
| Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors (NCT02843204) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections (NCT02687906) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) | 2016-07-01 |
| A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor (NCT02640833) | AbbVie | 2016-07-01 |